论文部分内容阅读
本文介绍应用双盲法对比先锋霉素Ⅳ与复方新诺明合剂治疗妇女尿道感染的效果。 100例症状性与无症状性尿路感染妇女随机分为先锋霉素Ⅳ组(50例)与复方新诺明组(50例)。两组平均年龄(30～32岁)、症状、肾功能及肾盂造影结果均相似,两组感染细菌也相似,均以大肠杆菌为主,余为奇异变形菌或细球菌属。患者均未怀孕,无导尿管所致感染,均作血尿素(均在40毫克/100毫升以下)或血浆肌酐测定(均在1.3毫克/100毫升以下)以及静脉肾盂造影。
This article describes the application of double-blind method compared to Pioneer ADM and cotrimoxazole mixture of women in the treatment of urinary tract infection. 100 women with symptomatic and asymptomatic urinary tract infection were randomly divided into Pioneer ADM group (n = 50) and cotrimoxazole group (n = 50). The average age of both groups (30 to 32 years), symptoms, renal function and pyelography were similar, the two groups of infected bacteria are similar, are E. coli-based, more than the genus Proteus or Actinococcus. None of the patients were pregnant and had no catheter-induced infections. Both were given either urea (both at 40 mg / 100 mL) or plasma creatinine (both at 1.3 mg / 100 mL) and IVP.